Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Januar 2022

Genmab — Januar 2022

Planlagt Fastgjort Låst Flyttet Genmab
1.2k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • Helge_LarsenPI-redaktørH Offline
    Helge_LarsenPI-redaktørH Offline
    Helge_LarsenPI-redaktør
    wrote on sidst redigeret af
    #1209

    God morgen. 🙂

    1 Reply Last reply
    0
    • H Offline
      H Offline
      HHM
      wrote on sidst redigeret af
      #1210

      Godmorgen 🙂 Jeg tænker ikke at vi så bunden i sidste uge

      1 Reply Last reply
      0
      • D Offline
        D Offline
        deleted-user
        wrote on sidst redigeret af
        #1211

        Godmorgen. Tak for bidraget @HHM - tillader mig, at linke til support siden for Proinvestor.com, hvor man også kan bidrage 🙂 https://www.proinvestor.com/donation

        1 Reply Last reply
        0
        • H Offline
          H Offline
          HHM
          wrote on sidst redigeret af
          #1212

          Tsk-tsk ,.. lige over ,.. se evt på muligheden i en dybere bund istedet for sarkasmen 🙂

          1 Reply Last reply
          0
          • D Offline
            D Offline
            deleted-user
            wrote on sidst redigeret af
            #1213

            Tak. Kan anbefale chatgruppen for "aktiesnakken" eller "debat-området", hvor der kan føres mere generelle indlæg, som ikke nødvendigvis rammer Genmab chatten spot on 😉

            1 Reply Last reply
            0
            • BulderB Offline
              BulderB Offline
              Bulder
              wrote on sidst redigeret af
              #1214

              Det er store biotek-dag i dag. Bava, gen og zeal strides om topplaceringen.

              1 Reply Last reply
              0
              • P Offline
                P Offline
                ProinvestorNEWS
                wrote on sidst redigeret af
                #1215

                Aktier/åbning: C25 helt i grønt - forsikringsselskaber slipper billigt
                https://www.proinvestor.com/investornyt/773502/aktier-abning-c25-helt-i-gront-forsikringsselskaber-slipper-billigt

                1 Reply Last reply
                0
                • P Offline
                  P Offline
                  ProinvestorNEWS
                  wrote on sidst redigeret af
                  #1216

                  Aktier/middag: C25-rutsjebaneturen fortsætter med biotek i topform
                  https://www.proinvestor.com/investornyt/773530/aktier-middag-c25-rutsjebaneturen-fortsaetter-med-biotek-i-topform

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #1217

                    H.C. Wainwright analyst Raghuram Selvaraju upgraded Genmab to Buy -I can't see if there is a new PT

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #1218

                      $47, same as they had before i think

                      1 Reply Last reply
                      0
                      • P Offline
                        P Offline
                        ProinvestorNEWS
                        wrote on sidst redigeret af
                        #1219

                        Genmab/HC Wainwright: ADR-notering hæves til "køb" fra "neutral"
                        https://www.proinvestor.com/investornyt/773555/genmab-hc-wainwright-adr-notering-haeves-til-kob-fra-neutral

                        1 Reply Last reply
                        0
                        • nohopeN Offline
                          nohopeN Offline
                          nohope
                          wrote on sidst redigeret af
                          #1220

                          No change,
                          still 47 USD

                          1 Reply Last reply
                          0
                          • DarvinD Offline
                            DarvinD Offline
                            Darvin
                            wrote on sidst redigeret af
                            #1221

                            Og de 47$ svarer til rundt regnet kurs 3.140 🙂

                            1 Reply Last reply
                            0
                            • Helge_LarsenPI-redaktørH Offline
                              Helge_LarsenPI-redaktørH Offline
                              Helge_LarsenPI-redaktør
                              wrote on sidst redigeret af
                              #1222

                              🙂

                              1 Reply Last reply
                              0
                              • StockBullS Offline
                                StockBullS Offline
                                StockBull
                                wrote on sidst redigeret af
                                #1223

                                👍

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #1224

                                  Daratumumab for treatment-refractory antibody-mediated diseases in neurology https://onlinelibrary.wiley.com/doi/10.1111/ene.15266

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #1225

                                    i said last week InnovaTV 205 was already combining with Keytruda , but not Keytruda and chemo together; they now add 1 arm to include that combo, possibly even a quad combination https://clinicaltrials.gov/ct2/history/NCT03786081?A=13&B=14&C=merged#StudyPageTop

                                    1 Reply Last reply
                                    0
                                    • D Offline
                                      D Offline
                                      Doublo
                                      wrote on sidst redigeret af
                                      #1226

                                      HC Wainwright co hæver kursen til køb fra neutral og deres kurs på Genmab er. 47$

                                      1 Reply Last reply
                                      0
                                      • D Offline
                                        D Offline
                                        Doublo
                                        wrote on sidst redigeret af
                                        #1227

                                        undskyld "gammel nyhed"

                                        1 Reply Last reply
                                        0
                                        • E Offline
                                          E Offline
                                          E_L
                                          wrote on sidst redigeret af
                                          #1228

                                          Janssen Submits Marketing Authorisation Application to the European Medicines Agency Seeking Approval of Bispecific Antibody Teclistamab for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma https://www.businesswire.com/news/home/20220128005418/en/Janssen-Submits-Marketing-Authorisation-Application-to-the-European-Medicines-Agency-Seeking-Approval-of-Bispecific-Antibody-Teclistamab-for-the-Treatment-of-Patients-with-Relapsed-or-Refractory-Multiple-Myeloma

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper